{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:57:48Z","timestamp":1774925868071,"version":"3.50.1"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FP7 EU project DEMO-NOPERSIST"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0197825","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T17:42:34Z","timestamp":1527874954000},"page":"e0197825","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis"],"prefix":"10.1371","volume":"13","author":[{"given":"Chiara","family":"Della Bella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Spinicci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Bartalesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"Benagiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Truthmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Tapinassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Troilo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"D\u2019Elios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba","family":"Alnwaisri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0650-3090","authenticated-orcid":true,"given":"Eduard","family":"Shuralev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahavir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Bartoloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9160-0930","authenticated-orcid":true,"given":"Mario Milco","family":"D\u2019Elios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Global Tuberculosis report 2017. Available from: http:\/\/www.who.int\/tb\/publications\/global_report\/en\/<\/ext-link>"},{"key":"ref2","unstructured":"World Health Organization. Guidelines on the Management of Latent Tuberculosis Infection. Geneva, 2015. Available from: http:\/\/www.who.int\/tb\/publications\/latent-tuberculosis-infection\/en\/<\/ext-link>"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1128\/MMBR.00010-14","article-title":"Latent Tuberculosis Infection: Myths, Models, and Molecular Mechanisms","volume":"78","author":"NK Dutta","year":"2014","journal-title":"Microbiol Mol Biol Rev"},{"issue":"22","key":"ref4","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection","volume":"372","author":"H Getahun","year":"2015","journal-title":"N Engl J Med"},{"key":"ref5","first-page":"27656733","author":"LC Kahwati","year":"2016"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1164\/rccm.201703-0446ED","article-title":"AJRCCM: 100-Year Anniversary. Focus on Tuberculosis","volume":"195","author":"NW Schluger","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"ref7","unstructured":"Centers for Disease Control and prevention. Interferon-Gamma Release Assays (IGRAs)\u2014Blood Tests for TB Infection. MMWR 2010; 59 (No.RR-5). Available from: http:\/\/www.cdc.gov\/tb\/publications\/factsheets\/testing\/IGRA.htm<\/ext-link>"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"M Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-1119(98)00134-6","article-title":"Host vector system for high-level expression and purification of recombinant, enzymatically active alanine dehydrogenase of Mycobacterium tuberculosis","volume":"212","author":"B Hutter","year":"1998","journal-title":"Gene"},{"issue":"Pt 3","key":"ref10","first-page":"669","article-title":"Properties of the 40 kDa antigen of Mycobacterium tuberculosis, a functional L-alanine dehydrogenase","volume":"343","author":"B Hutter","year":"1999"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jmb.2008.01.091","article-title":"Three-dimensional structures of apo- and holo-L-alanine dehydrogenase from Mycobacterium tuberculosis reveal conformational changes upon coenzyme binding","volume":"377","author":"D Agren","year":"2008","journal-title":"J Mol Biol"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/gene.2013.26","article-title":"Identification of biomarkers for Mycobacterium tuberculosis infection and disease in BCG-vaccinated young children in Southern India","volume":"14","author":"S Dhanasekaran","year":"2013","journal-title":"Genes Immun"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"e46041","DOI":"10.1371\/journal.pone.0046041","article-title":"Potential role of M. tuberculosis specific IFN-gamma and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis","volume":"7","author":"E Chiappini","year":"2012","journal-title":"Plos One"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1128\/JB.05914-11","article-title":"ald of Mycobacterium tuberculosis encodes both the alanine dehydrogenase and the putative glycine dehydrogenase","volume":"194","author":"MM Giffin","year":"2012","journal-title":"J Bacteriol"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"e0155522","DOI":"10.1371\/journal.pone.0155522","article-title":"Role of Alanine Dehydrogenase of Mycobacterium tuberculosisduring Recovery from Hypoxic Nonreplicating Persistence","volume":"11","author":"MM Giffin","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1684\/ecn.2017.0391","article-title":"Interferon Gamma Release Assay in response to PE35\/PPE68 proteins: a promising diagnostic method for diagnosis of latent tuberculosis","volume":"28","author":"S Mahmoudi","year":"2017","journal-title":"Eur Cytokine Netw"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"e17813","DOI":"10.1371\/journal.pone.0017813","article-title":"Whole-blood flow-cytometric analysis of antigen-specific CD4 T cell cytokine profiles distinguishes active tuberculosis from non-active states","volume":"6","author":"U Sester","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1469-0691.2009.03104.x","article-title":"Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls","volume":"16","author":"R Biselli","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"ref19","first-page":"275","article-title":"IFN-\u03b3 and IL-2 Responses to Recombinant AlaDH against ESAT-6\/CFP-10 Fusion Antigens in the Diagnosis of Latent versus Active Tuberculosis Infection","volume":"42","author":"B Movahedi","year":"2017","journal-title":"Iran J Med Sci"},{"issue":"RR-6","key":"ref20","first-page":"1","article-title":"American Thoracic Society","volume":"9","year":"2000","journal-title":"MMWR Recomm Rep"},{"issue":"RR-5","key":"ref21","first-page":"1","article-title":"IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010","volume":"59","author":"GH Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"h6747","DOI":"10.1136\/bmj.h6747","article-title":"on behalf of the Guideline Development Group. Tuberculosis\u2014diagnosis, management, prevention, and control: summary of updated NICE guidance","volume":"352","author":"LE Hoppe","year":"2016","journal-title":"BMJ"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/cid\/ciw778","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children","volume":"64","author":"DM Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"ref24","year":"2016"},{"key":"ref25","unstructured":"National Institute for health and Care Excellence. NICE guidelines. 2016; Available from: nice.org.uk\/guidance\/ng33<\/ext-link>."},{"key":"ref26","article-title":"Centers for Disease Control and Prevention (CDC), developed in partnership with the New Jersey Medical School Global Tuberculosis Institute","year":"2013","journal-title":"Latent Tuberculosis Infection: A Guide for Primary Health Care Providers"},{"issue":"4857","key":"ref27","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.3287615","article-title":"Measuring the Accuracy of Diagnostic Systems","volume":"240","author":"JA Swet","year":"1988","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The Immune Response in Tuberculosis","volume":"31","author":"A O'Garra","year":"2013","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ni.3048","article-title":"The balance between protective and pathogenic immune responses in the TB-infected lung","volume":"16","author":"IM Orme","year":"2015","journal-title":"Nat Immunol"},{"issue":"13","key":"ref30","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/JB.184.13.3485-3491.2002","article-title":"Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins","volume":"184","author":"I Rosenkrands","year":"2002","journal-title":"J Bacteriol"},{"issue":"8","key":"ref31","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/CVI.00111-09","article-title":"Immunogenicity of Novel DosR Regulon-Encoded Candidate Antigens of Mycobacterium tuberculosis in Three High-Burden Populations in Africa","volume":"16","author":"GF Black","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.micinf.2006.03.018","article-title":"Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis","volume":"8","author":"EM Leyten","year":"2006","journal-title":"Microbes Infect"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1183\/09031936.00140009","article-title":"Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection","volume":"36","author":"D Goletti","year":"2010","journal-title":"Eur Respir J"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2958.2002.02779.x","article-title":"Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling","volume":"43","author":"JC Betts","year":"2002","journal-title":"Mol Microbiol"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jinf.2016.11.010","article-title":"Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease","volume":"74","author":"EJ Won","year":"2017","journal-title":"J Infect"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"e0166501","DOI":"10.1371\/journal.pone.0166501","article-title":"Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-\u03b3 Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation","volume":"11","author":"Q Sun","year":"2016","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tube.2016.06.001","article-title":"Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection","volume":"102","author":"J Wu","year":"2017","journal-title":"Tuberculosis (Edinb)"},{"issue":"22","key":"ref38","doi-asserted-by":"crossref","first-page":"18493","DOI":"10.1021\/acsami.7b03211","article-title":"Novel Electrochemiluminescence Sensing Platform for the Precise Analysis of Multiple LTBI Markers","volume":"9","author":"B Zhou","year":"2017","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5588\/ijtld.16.0176","article-title":"Potential biomarkers associated with discrimination between latent and active pulmonary tuberculosis","volume":"21","author":"R Kamakia","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"e0152483","DOI":"10.1371\/journal.pone.0152483","article-title":"Combined analysis of IFN-\u03b3, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT supernatant is useful for distinguishing active tuberculosis from latent infection","volume":"11","author":"M Suzukawa","year":"2016","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0197825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T01:25:40Z","timestamp":1604366740000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0197825"}},"subtitle":[],"editor":[{"given":"Francesco","family":"Dieli","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0197825","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}